Opaleye Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,000	Closed	-$2.66M	–	64
2020 Q3	$2.66M	Buy	+15,000	New	+$2.66M	0.52%	42